Dysregulation of complement factor H in juvenile-onset systemic lupus erythematosus patients

Eman Eissa, Botros Morcos, Dalia Dorgham, Naglaa Kholoussi

DOI: 10.46497/ArchRheumatol.2022.9217

Issue: Volume 37 - Issue 3 - September 2022
1059 942

Serum BMP-2 and BMP-4 levels and their relationship with disease activity in patients with rheumatoid arthritis and ankylosing spondylitis

Ali Erhan Özdemirel, Serdar Can Güven, Zühre Sarı Sürmeli, Ayla Özyuvalı, Memet Kurt, Diana Rüstemova, Ayşe Peyman Yalçın Sayan, Hüseyin Tutkan, Şebnem Ataman

DOI: 10.46497/ArchRheumatol.2022.9819

Issue: Volume 37 - Issue 3 - September 2022
1291 997

The effects of glucocorticoid treatment on cardiovascular system in patients with systemic lupus erythematosus

Dominika Blachut, Brygida Przywara-Chowaniec, Jan Harpula, Andrzej Tomasik, Ewa Nowalany-Kozielska, Beata Morawiec

DOI: 10.46497/ArchRheumatol.2022.9255

Issue: Volume 37 - Issue 4 - December 2022
913 1084

MT-CO1 expression in nine organs and tissues of different-aged MRL/lpr mice: Investigation of mitochondrial respiratory chain dysfunction at organ level in systemic lupus erythematosus pathogenesis

Xinglan Huang, Peng Yan, Xinghua Song, Suiying Zhang, Yuqiong Deng, Caifeng Huang, Xiaoqing Zhao, Sheng Liu, Xiping Cheng, Dongjiang Liao

DOI: 10.46497/ArchRheumatol.2022.9168

Issue: Volume 37 - Issue 4 - December 2022
1190 1281

The association of urinary plasmin level with renal involvement and disease flare among systemic lupus erythematosus patients

Rasha Fawzy, Mounir Serag, Amal Soliman, Sania Elwia, Samia Mojahed

DOI: 10.46497/ArchRheumatol.2022.9307

Issue: Volume 37 - Issue 4 - December 2022
923 840

Identification of a novel mutation in complement receptor 2 in Chinese familial systemic lupus erythematosus

Yuewu Tang, Yi Luo

DOI: 10.46497/ArchRheumatol.2022.9167

Issue: Volume 37 - Issue 4 - December 2022
901 935

Insulin resistance and adverse lipid profile in untreated very early rheumatoid arthritis patients: A single-center, cross-sectional study in China

Lu Ye, Xin Zhang, Huaxiang Wu, Yahui Chen, Haibo Zhou, Qiaohong Wang, Weihong Xu

DOI: 10.46497/ArchRheumatol.2022.9117

Issue: Volume 37 - Issue 4 - December 2022
952 1047

Antinuclear antibody-negative systemic lupus erythematosus: How many patients and how to identify?

Hejun Li, Yiqing Zheng, Ling Chen, Shunping Lin

DOI: 10.46497/ArchRheumatol.2022.9366

Issue: Volume 37 - Issue 4 - December 2022
1927 1322

Serum cystatin C and βeta-2 microglobulin as potential biomarkers in children with lupus nephritis

Eman Baraka, Nashwa Hashaad, Walid Abdelhalim, Gehan Elolemy

DOI: 10.46497/ArchRheumatol.2023.8520

Issue: Volume 38 - Issue 1 - March 2023
798 843

Muscle architecture in patients with primary Sjögren syndrome

Duygu Tecer, Dilek Eker Büyüksireci, Zafer Günendi, Jale Meray, Feride Göğüs

DOI: 10.46497/ArchRheumatol.2023.9414

Issue: Volume 38 - Issue 1 - March 2023
722 817

Pro-apoptotic Bax mRNA expression: A novel predictor for systemic lupus erythematosus disease flare-up

Rasha N Yousef, Abeer Ramadan, Eman Awadallah, Alshaimaa R Alnaggar, Noha M Khalil, Mervat E.Behiry, Asmaa Ali, Hesham Gamal El Dine

DOI: 10.46497/ArchRheumatol.2023.9448

Issue: Volume 38 - Issue 1 - March 2023
725 874

Proprotein convertase subtilisin/kexin 9 (PCSK9) in patients with diffuse systemic sclerosis: A marker of disease activity and severe disease manifestations with potential therapeutic implementations

Joy Artin, Yumn A. Elsabagh, Laila Rashed, Mohamed A. Hussein

DOI: 10.46497/ArchRheumatol.2023.9638

Issue: Volume 38 - Issue 2 - June 2023
553 623

Pediatric Behçet’s disease: Experience of a single tertiary center

Ceyhun Açarı, Rana İşgüder, Rüya Torun, Balahan Makay, Şevket Erbil Ünsal

DOI: 10.46497/ArchRheumatol.2023.9651

Issue: Volume 38 - Issue 2 - June 2023
681 651

Association between levels of serum and urinary B cell-activating factor and systemic lupus erythematosus disease activity

Maryam Rezazadeh, Mohammad Hasan Jokar, Seyedeh Mehrnaz Aghili, Zahra Mirfeizi, Mahmoud Mahmoudi, Negar Morovatdar, Kamila Hashemzadeh

DOI: 10.46497/ArchRheumatol.2023.9549

Issue: Volume 38 - Issue 3 - September 2023
660 550

Mortality in a cohort of Egyptian systemic lupus erythematosus patients: A comparison with African, Arabic, and Mediterranean studies

Sherif Gamal, Hanaa Rady, Nesreen Sobhy, Ibrahem Siam, Ahmed Soliman, Fatema Elgengehy

DOI: 10.46497/ArchRheumatol.2023.9860

Issue: Volume 38 - Issue 3 - September 2023
473 496

The effects of Lactobacillus delbrueckii and Lactobacillus rhamnosus on cytokines and their related molecules: An ex vivo study on patients with systemic lupus erythematosus

Atefeh Alaei, Mahmoud Mahmoudi, Maryam Sahebari, Zohreh Vahidi, Nafiseh Tabasi, Maryam Rastin

DOI: 10.46497/ArchRheumatol.2023.9941

Issue: Volume 38 - Issue 4 - December 2023
445 530

Early effectiveness and safety analysis of belimumab in addition to standard treatment in patients with systemic lupus erythematosus

Lingyan He, Mingming Yan, Rui Wen, Jiali Li

DOI: 10.46497/ArchRheumatol.2024.9977

Issue: Online First
0 17527

Correlation between clinical disease activity and sacroiliac magnetic resonance imaging detection in axial spondyloarthropathy

Ozenc Inan, Ebru Aytekin, Yasemin Pekin Dogan, Ilhan Nahit Mutlu, Kübra Aydemir, Nuran Oz, Nil Sayiner Caglar

DOI: 10.46497/ArchRheumatol.2024.10401

Issue: Volume 39 - Issue 1 - March 2024
243 275

Left ventricular systolic function assessed by standard and advanced echocardiographic techniques in patients with systemic lupus erythematosus: A systemic review and meta-analysis

Maka Gegenava, Zviad Kirtava, William KF Kong, Tea Gegenava

DOI: 10.46497/ArchRheumatol.2024.10131

Issue: Volume 39 - Issue 1 - March 2024
211 195

The cultural differences in transition assessment: Evaluation of TRANSITION-Q and STARx scales on Turkish rheumatic patients

Ramazan Emre Yiğit, Şengül Çağlayan, Betül Sözeri

DOI: 10.46497/ArchRheumatol.2024.10379

Issue: Online First
0 341